Mumbai, Thursday, February 5, 2026: Bliss GVS Pharma Ltd (BSE: BLISSGVS) recorded a block deal during the morning trading window on Thursday, with a large transaction executed at a discount to the previous closing price.
Block Deal Executed in Morning Session
The transaction took place during Session 1, the morning block deal window that operates between 08:45 am and 09:00 am. A total of 14,00,000 equity shares were traded at a fixed price of ₹180.10 per share.Block Deal Snapshot
| Particulars | Details |
|---|---|
| Symbol | BLISSGVS |
| Series | BL |
| Block Deal Session | Morning Session |
| Shares Traded | 14,00,000 |
| Deal Price | ₹180.10 |
| Deal Value | ₹25.21 crore |
| Previous Close | ₹184.28 |
| Percentage Change | -2.27% |
Price Context and Market Reading
The block deal was carried out at a 2.27 percent discount to the previous closing price of ₹184.28. Such pricing is typical for large-volume negotiated trades and often reflects portfolio realignment or stake reshuffling by institutional or high-net-worth investors.About the Company
Bliss GVS Pharma Ltd is engaged in the manufacture and marketing of pharmaceutical formulations, with operations spanning domestic and export markets. The company is listed on the BSE under the BL series and caters to a wide range of therapeutic segments.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.